1. Influence of model-predicted rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndrome. (July 2019) Authors: Zhang, Liping; Yan, Xiaoyu; Nandy, Partha; Willmann, Stefan; Fox, Keith A. A.; Berkowitz, Scott D.; Sharma, Amarnath; Hermanowski-Vosatka, Anne; Schmidt, Stephan; Weitz, Jeffrey I.; Garmann, Dirk; Peters, Gary Journal: Therapeutic advances in cardiovascular disease Issue: Volume 13(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Randomized phase 2 trial comparing JNJ‐9375, a thrombin‐directed antibody, with apixaban for prevention of venous thrombosis. (13th October 2019) Authors: Weitz, Jeffrey I.; Segers, Annelise; Raskob, Gary; Roberts, Robin S.; Francis, Charles; Lassen, Michael Rud; Fuji, Takeshi; Swaim, Renée M.; Lee, Michael; Peters, Gary; DiBattiste, Peter M.; Tesfaye, Fisseha; Strony, John Journal: Journal of thrombosis and haemostasis Issue: Volume 17:Number 12(2019) Page Start: 2081 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Irony and Singularity : Aesthetic Education from Kant to Levinas /: Aesthetic Education from Kant to Levinas. (2017) Authors: Peters, Gary Record Type: Book Extent: 1 online resource (204 pages) View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Exosite 1 thrombin inhibition with JNJ-64179375 inhibits thrombus formation in a human translational model of thrombosis. Issue 3 (26th October 2018) Authors: Wilson, Simon J; Connolly, Thomas M; Peters, Gary; Ghosh, Atalanta; Johnson, Maureen; Newby, David E Journal: Cardiovascular research Issue: Volume 115:Issue 3(2019) Page Start: 669 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis‐mediated conditions. (23rd May 2013) Authors: Sarich, Troy C.; Peters, Gary; Berkowitz, Scott D.; Misselwitz, Frank; Nessel, Christopher C.; Burton, Paul; Cook‐Bruns, Nancy; Lensing, Anthonie W.A.; Haskell, Lloyd; Perzborn, Elisabeth; Kubitza, Dagmar; Moore, Kenneth T.; Jalota, Sanjay; Weber, Juergen; Pan, Guohua; Sun, Xiang; Westermeier, To... Journal: Annals of the New York Academy of Sciences Issue: Volume 1291(2013) Page Start: 42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial. (September 2016) Authors: Hart, Robert G; Sharma, Mukul; Mundl, Hardi; Shoamanesh, Ashkan; Kasner, Scott E; Berkowitz, Scott D; Pare, Guillaume; Kirsch, Bodo; Pogue, Janice; Pater, Calin; Peters, Gary; Davalos, Antoni; Lang, Wilfried; Wang, Yongjun; Wang, Yilong; Cunha, Luis; Eckstein, Jens; Tatlisumak, Turgut; Shamalov, ... Journal: European stroke journal Issue: Volume 1:Number 3(2016) Page Start: 146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Reviews: Reviews. Issue 1 (8th December 2017) Authors: Peters, Gary Journal: Popular music Issue: Volume 37:Issue 1(2018) Page Start: 146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A Cross‐Study Analysis Evaluating the Effects of Food on the Pharmacokinetics of Rivaroxaban in Clinical Studies. (5th July 2017) Authors: Zhang, Liping; Peters, Gary; Haskell, Lloyd; Patel, Purve; Nandy, Partha; Moore, Kenneth Todd Journal: Journal of clinical pharmacology Issue: Volume 57:Number 12(2017) Page Start: 1607 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Giving monoclonal antibodies to healthy volunteers in phase 1 trials: is it safe?. (23rd July 2013) Authors: Tranter, Elizabeth; Peters, Gary; Boyce, Malcolm; Warrington, Steve Journal: British journal of clinical pharmacology Issue: Volume 76:Number 2(2013:Aug.) Page Start: 164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The impact of relative CEO compensation on not-for-profit contributions. Issue 2 (20th September 2021) Authors: Kaden, Stacey; Peters, Gary; Sanchez, Juan Manuel; Fleischman, Gary M. Journal: Journal of public budgeting, accounting & financial management Issue: Volume 34:Issue 2(2022) Page Start: 210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗